Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5733_Библиотеки_им_академика_М_И_Перельмана
.pdf
47
However, since benzylmorphine decomposes rather than boils at high
temperatures, this method may not be directly applicable.
Solubility Testing: Solubility testing involves dissolving benzylmorphine in
various solvents, such as water, ethanol, and chloroform, to determine its
solubility characteristics. This information is useful for formulation
purposes and assessing the compound's physical properties.
Crystallization: Crystallization is a method used to purify benzylmorphine
by selectively precipitating it from a solution in its solid crystalline form.
The resulting crystals can be analyzed for purity and morphology using
microscopy techniques.
Particle Size Analysis: Particle size analysis techniques, such as laser
diffraction or microscopy, can be used to determine the size distribution of
benzylmorphine particles in a sample. This information is relevant for
pharmaceutical formulations and process optimization.
Density Measurement: Density measurement can provide information
about the compactness and purity of a benzylmorphine sample. The
density of benzylmorphine can be determined using techniques such as
pycnometry or volumetric methods.
Thermal Analysis: Thermal analysis techniques, such as differential
scanning calorimetry (DSC) or thermogravimetric analysis (TGA), can be
used to study the thermal behavior and stability of benzylmorphine under
different temperature conditions.
Spectroscopic Techniques: Spectroscopic techniques, including infrared
(IR) spectroscopy and UV-visible spectroscopy, can be used to
characterize the molecular structure and identify functional groups
present in benzylmorphine.
Chemical method: Chemical methods of analysis for benzylmorphine involve
techniques that directly involve chemical reactions or interactions to identify or
quantify the substance. These methods are often used to determine the presence,
concentration, or purity of benzylmorphine in a sample. Some common chemical
methods of analysis for benzylmorphine include:
Thin-Layer Chromatography (TLC): TLC is a chromatographic technique
used to separate and identify compounds in a mixture. In benzylmorphine
analysis, a TLC plate coated with a stationary phase is spotted with the
sample containing benzylmorphine and developed using a suitable solvent
system. The separated spots can be visualized using UV light or chemical
reagents specific to benzylmorphine.
High-Performance Liquid Chromatography (HPLC): HPLC is a powerful
analytical technique used for the separation, identification, and
quantification of benzylmorphine in a sample. In HPLC analysis, a liquid
mobile phase is pumped through a column packed with a stationary phase,
https://t.me/med1917
48
separating benzylmorphine from other components based on their
interactions with the stationary phase. Detection is typically done using
UV-visible spectroscopy.
Gas Chromatography (GC): GC is a chromatographic technique used to
separate volatile compounds, making it less suitable for benzylmorphine
analysis due to its low volatility. However, derivatization of
benzylmorphine to a more volatile form can enable its analysis by GC. GC
analysis involves vaporizing the sample and separating its components
using a capillary column, followed by detection using a suitable detector
such as a flame ionization detector (FID).
Mass Spectrometry (MS): MS is a powerful technique used to identify and
quantify compounds based on their mass-to-charge ratio. In MS analysis of
benzylmorphine, the compound is ionized and fragmented into
characteristic ions, which are then detected and analyzed to determine the
compound's identity and concentration.
Colorimetric Methods: Colorimetric methods involve the use of specific
chemical reagents that react with benzylmorphine to produce a colored
product. The intensity of the color is proportional to the concentration of
benzylmorphine in the sample, allowing for qualitative or quantitative
analysis.
Titration Methods: Titration methods involve the reaction of
benzylmorphine with a known reagent of known concentration to
determine its concentration in the sample. Acid-base titration or
oxidation-reduction titration methods can be used for benzylmorphine
analysis, depending on the functional groups present in the compound.
https://t.me/med1917
49
BETA-ACETYLMETHADOL
Scientific Name: Beta-acetylmethadol is also known as LAAM (levo-alpha-
acetylmethadol) or levacetylmethadol.
Molecular Structure:
A) Physical Properties
Appearance: Beta-acetylmethadol typically appears as a white crystalline
powder or as small crystals.
Color: White.
Odor: Typically odorless.
Taste: Not commonly reported.
Melting Point: Approximately [Melting point information not readily
available].
Boiling Point: Approximately [Boiling point information not readily
available].
Solubility:
Water: Sparingly soluble.
Alcohol: Soluble.
B) Chemical Properties:
Chemical Formula: C21H29NO2.
Chemical Classification: Beta-acetylmethadol is a synthetic opioid
analgesic.
Functional Group: Contains an acetyl group (-COCH3).
pH: Not commonly reported.
https://t.me/med1917
50
How it is made and obtained ?
Beta-acetylmethadol (also known as LAAM or levacetylmethadol) is
synthesized in laboratory settings through a multistep chemical synthesis process.
The specific synthetic route and chemical precursors used may vary depending on
the manufacturer and synthesis method employed. However, the general process
involves the following steps:
Synthesis of Intermediate Compounds: The synthesis typically begins with
the preparation of intermediate compounds that serve as building blocks
for Beta-acetylmethadol. These intermediates may undergo various
chemical reactions and transformations to introduce specific functional
groups and structural motifs necessary for the final compound.
Acetylation Reaction: One key step in the synthesis of Beta-acetylmethadol
involves the acetylation of a suitable precursor compound. This reaction
typically involves the reaction of the precursor compound with acetic
anhydride (or acetyl chloride) in the presence of a catalyst or base to
introduce the acetyl group (-COCH3) onto the molecule.
Purification and Isolation: After the acetylation reaction, the crude
product undergoes purification to remove impurities and isolate the
desired Beta-acetylmethadol compound. Purification techniques may
include recrystallization, chromatography, or filtration methods.
Formulation: Once purified, Beta-acetylmethadol may be formulated into
various pharmaceutical dosage forms, such as tablets or solutions,
depending on the intended route of administration and clinical use. The
formulation may involve the addition of excipients, binders, and other
ingredients to improve stability, bioavailability, and patient acceptability.
Beta-acetylmethadol is obtained through licensed pharmaceutical
manufacturing facilities that adhere to strict regulations and quality
control standards. It is not naturally occurring and cannot be obtained
from natural sources. The production and distribution of Beta-
acetylmethadol are tightly regulated due to its classification as a potent
opioid analgesic and controlled substance.
Route of Administration: Beta-acetylmethadol is primarily administered orally in
the form of tablets or solutions. The oral route is the most common and convenient
method of administration for Beta-acetylmethadol. The medication is typically
ingested with water and absorbed through the gastrointestinal tract into the
bloodstream.
Pharmacological Actions: Beta-acetylmethadol is a synthetic opioid analgesic
that exerts its pharmacological actions primarily through interaction with opioid
https://t.me/med1917
51
receptors in the central nervous system. Here are the key pharmacological actions
of Beta-acetylmethadol:
Analgesia: Beta-acetylmethadol provides analgesic effects by binding to
mu-opioid receptors in the brain and spinal cord. Activation of these
receptors inhibits the transmission of pain signals and alters pain
perception, resulting in pain relief.
Respiratory Depression: Like other opioids, Beta-acetylmethadol can
cause respiratory depression by suppressing the activity of respiratory
centers in the brainstem. This effect can lead to decreased respiratory rate
and depth, which may result in respiratory insufficiency or respiratory
arrest, particularly at higher doses.
Sedation: Beta-acetylmethadol has sedative properties, leading to
drowsiness, lethargy, and a general feeling of calmness or relaxation. This
effect is mediated through the modulation of neurotransmitter activity in
the central nervous system, including the enhancement of GABAergic
neurotransmission.
Euphoria and Mood Alteration: Beta-acetylmethadol can induce feelings of
euphoria, well-being, and pleasure, commonly referred to as a "high." This
effect is mediated by the activation of mu-opioid receptors in the brain's
reward pathway, leading to the release of dopamine and other
neurotransmitters associated with pleasure and reward.
Physical Dependence and Tolerance: Prolonged use of Beta-
acetylmethadol can lead to the development of physical dependence,
where the body becomes adapted to the presence of the drug and
experiences withdrawal symptoms upon discontinuation. Additionally,
tolerance may develop, requiring higher doses of the drug to achieve the
same level of analgesia.
Gastrointestinal Effects: Beta-acetylmethadol can cause constipation by
decreasing gastrointestinal motility through the activation of opioid
receptors in the enteric nervous system. This effect is due to the inhibition
of acetylcholine release and subsequent smooth muscle relaxation in the
gastrointestinal tract.
Cardiovascular Effects: Beta-acetylmethadol can cause peripheral
vasodilation and orthostatic hypotension, leading to a decrease in blood
pressure. These effects are mediated by the release of histamine and the
inhibition of sympathetic nervous system activity.
Antitussive Activity: Beta-acetylmethadol exhibits antitussive (cough-
suppressing) activity by acting on the cough center in the medulla
oblongata of the brainstem. It reduces the sensitivity of the cough reflex
and suppresses coughing.
https://t.me/med1917
52
Analysis
Physical Method:
Melting Point Determination: Melting point determination is a commonly
used physical method to assess the purity of Beta-acetylmethadol. The
observed melting point can be compared to the known literature value to
determine the compound's identity and purity.
Appearance and Color: The physical appearance and color of Beta-
acetylmethadol can be visually inspected and compared to reference
standards to assess its purity and quality.
Solubility Testing: Solubility testing involves dissolving Beta-
acetylmethadol in various solvents, such as water, ethanol, and
chloroform, to determine its solubility characteristics. This information is
useful for formulation purposes and assessing the compound's physical
properties.
Particle Size Analysis: Particle size analysis techniques, such as laser
diffraction or microscopy, can be used to determine the size distribution of
Beta-acetylmethadol particles in a sample. This information is relevant for
pharmaceutical formulations and process optimization.
Crystallization: Crystallization is a purification technique used to isolate
Beta-acetylmethadol in its solid crystalline form. The resulting crystals can
be analyzed for purity and morphology using microscopy techniques.
Chemical method:
Chromatographic Techniques: Chromatographic techniques, such as high-
performance liquid chromatography (HPLC) and gas chromatography
(GC), are commonly used for chemical analysis of Beta-acetylmethadol.
These techniques separate Beta-acetylmethadol from other components in
a sample based on their interactions with the stationary phase, allowing
for identification and quantification.
Mass Spectrometry (MS): Mass spectrometry is a powerful technique used
to identify and quantify Beta-acetylmethadol based on its mass-to-charge
ratio. MS analysis involves ionizing the compound and measuring the mass
of its ions, providing information about its molecular structure and
composition.
Spectroscopic Techniques: Spectroscopic techniques, including infrared
(IR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy,
can be used to characterize the molecular structure of Beta-
acetylmethadol and identify functional groups present in the compound.
Colorimetric Methods: Colorimetric methods involve the use of specific
chemical reagents that react with Beta-acetylmethadol to produce a
https://t.me/med1917
53
colored product. The intensity of the color is proportional to the
concentration of Beta-acetylmethadol in the sample, allowing for
qualitative or quantitative analysis.
Titration Methods: Titration methods involve the reaction of Beta-
acetylmethadol with a known reagent of known concentration to
determine its concentration in the sample. Acid-base titration or
oxidation-reduction titration methods can be used for Beta-
acetylmethadol analysis.
https://t.me/med1917
54
BETA-HYDOXY-3-
METHYLFENTANYL
Scientific Name: The scientific name for Beta-hydroxy-3-methylfentanyl is N-[3-
Methyl-1-(2-phenylethyl)-4-piperidinyl]-N-phenyl-3-hydroxypropanamide.
Molecular Structure:
A) Physical Properties:
Appearance: Beta Hydroxy-3-Methylfentanyl typically appears as a white
crystalline powder or as small crystals.
Color: White.
Odour: Typically odorless.
Taste: Not commonly reported.
Melting Point: The melting point of Beta-Hydroxy-3-methylfentanyl is
approximately 85.2°C
Boiling Point: The boiling point of Beta-Hydroxy-3-methylfentanyl is
approximately 516.6°C
Molar Mass: The molar mass of Benzylmorphine is 375.4602 g/mol
Solubility:
Water: Sparingly soluble.
Alcohol: Soluble.
B) Chemical Properties:
Chemical Formula: C24H30N2O2.
Chemical Classification: Beta Hydroxy-3-Methylfentanyl is a synthetic
opioid analgesic.
Functional Group: Contains a hydroxyl (-OH) group.
https://t.me/med1917
55
How it is Made? From Where it is Obtained ?
Beta-hydroxy-3-methylfentanyl is a synthetic compound that is
manufactured in laboratory settings through chemical synthesis. The specific
synthetic route and chemical precursors used to produce Beta-hydroxy-3-
methylfentanyl may vary depending on the manufacturer and synthesis method
employed. However, the general process typically involves the following steps:
Chemical Synthesis: The synthesis of Beta-hydroxy-3-methylfentanyl
usually begins with the preparation of intermediate compounds that serve
as building blocks for the final product. These intermediates undergo
various chemical reactions and transformations to introduce specific
functional groups and structural motifs necessary for Beta-hydroxy-3-
methylfentanyl.
Hydroxylation Reaction: One key step in the synthesis of Beta-hydroxy-3-
methylfentanyl involves the hydroxylation of a suitable precursor
compound. This reaction introduces the hydroxyl (-OH) group onto the
molecule at a specific position, resulting in the formation of Beta-hydroxy-
3-methylfentanyl.
Purification and Isolation: After the synthesis reaction, the crude product
undergoes purification to remove impurities and isolate the desired Beta-
hydroxy-3-methylfentanyl compound. Purification techniques may include
recrystallization, chromatography, or filtration methods to obtain a pure
product.
Formulation: Once purified, Beta-hydroxy-3-methylfentanyl may be
formulated into various pharmaceutical dosage forms, such as tablets,
solutions, or transdermal patches, depending on the intended route of
administration and clinical use. Formulation may involve the addition of
excipients, binders, and other ingredients to improve stability,
bioavailability, and patient acceptability.
Beta-hydroxy-3-methylfentanyl is obtained through licensed
pharmaceutical manufacturing facilities that adhere to strict regulations
and quality control standards. It is not naturally occurring and cannot be
obtained from natural sources. The production and distribution of Beta-
hydroxy-3-methylfentanyl are tightly regulated due to its classification as
a potent opioid analgesic and controlled substance.
Route of Administration: Beta-hydroxy-3-methylfentanyl can be administered
through various routes depending on the formulation and clinical setting:
Intravenous (IV) Administration: Beta-hydroxy-3-methylfentanyl can be
administered intravenously by injecting it directly into a vein. This route
https://t.me/med1917
56
provides rapid onset of action and is often used in emergency situations or
during anesthesia induction in medical settings.
Transdermal Administration: Beta-hydroxy-3-methylfentanyl is also
available in transdermal patches that deliver the drug through the skin
over an extended period. Transdermal administration provides
continuous and controlled release of the medication, making it suitable for
chronic pain management.
Oral Administration: While less common, Beta-hydroxy-3-methylfentanyl
can be administered orally in the form of tablets or solutions. Oral
administration typically results in slower onset of action compared to
intravenous or transdermal routes.
Intramuscular (IM) or Subcutaneous (SC) Administration: Beta-hydroxy-
3-methylfentanyl may be administered intramuscularly or subcutaneously
in certain clinical situations where intravenous access is not available or
when a rapid onset of action is not required.
Pharmacological Actions: Beta-hydroxy-3-methylfentanyl is a synthetic opioid
analgesic that exerts its pharmacological actions primarily through interaction
with opioid receptors in the central nervous system. Here are the key
pharmacological actions of Beta-hydroxy-3-methylfentanyl:
Analgesia: Beta-hydroxy-3-methylfentanyl provides potent analgesic
effects by binding to mu-opioid receptors in the brain and spinal cord.
Activation of these receptors inhibits the transmission of pain signals and
alters pain perception, resulting in pain relief.
Respiratory Depression: Like other opioids, Beta-hydroxy-3-
methylfentanyl can cause respiratory depression by suppressing the
activity of respiratory centers in the brainstem. This effect can lead to
decreased respiratory rate and depth, which may result in respiratory
insufficiency or respiratory arrest, particularly at higher doses.
Sedation: Beta-hydroxy-3-methylfentanyl has sedative properties, leading
to drowsiness, lethargy, and a general feeling of calmness or relaxation.
This effect is mediated through the modulation of neurotransmitter
activity in the central nervous system, including the enhancement of
GABAergic neurotransmission.
Euphoria and Mood Alteration: Beta-hydroxy-3-methylfentanyl can induce
feelings of euphoria, well-being, and pleasure, commonly referred to as a
"high." This effect is mediated by the activation of mu-opioid receptors in
the brain's reward pathway, leading to the release of dopamine and other
neurotransmitters associated with pleasure and reward.
Physical Dependence and Tolerance: Prolonged use of Beta-hydroxy-3-
methylfentanyl can lead to the development of physical dependence,
where the body becomes adapted to the presence of the drug and
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана